| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Outlook Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 58.6K | Oct 3, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | Oct 1, 2025 | 2 | $0 | 4 | Oct 3, 2025 | Director |
| OTLK | Outlook Therapeutics, Inc. | Oct 1, 2024 | 3 | $0 | 4 | Oct 3, 2024 | Director |
| OTLK | Outlook Therapeutics, Inc. | Mar 7, 2024 | 1 | $0 | 4 | Mar 8, 2024 | Director |
| OTLK | Outlook Therapeutics, Inc. | Oct 4, 2023 | 1 | $0 | 4 | Oct 5, 2023 | Director |
| OTLK | Outlook Therapeutics, Inc. | Mar 29, 2023 | 1 | $0 | 4 | Mar 31, 2023 | Director |
| OTLK | Outlook Therapeutics, Inc. | Oct 5, 2022 | 1 | $0 | 4 | Oct 7, 2022 | Director |
| OTLK | Outlook Therapeutics, Inc. | Mar 23, 2022 | 1 | $0 | 4 | Mar 24, 2022 | Director |
| OTLK | Outlook Therapeutics, Inc. | Oct 5, 2021 | 1 | $0 | 4 | Oct 7, 2021 | Director |